Release of endogenous basic fibroblast growth factor (bFGF) has been shown to initiate smooth muscle cell (SMC) proliferation following balloon catheter denudation in rat arteries. The mechanisms that contribute to the continued replication of the cells that subsequently form the neointima are not well understood. We have examined expression of bFGF and fibroblast growth factor receptor 1 (FGFR-1) in luminal SMCs as well as endothelium at various times after injury, which allowed us to study both replicating as well as quiescent cells. fibroblast growth factor receptor-i * smooth muscle local differences in cellular gene transcription may be overlooked by using Northern analysis of RNA, in which the overall expression of the entire artery is analyzed. Localized differences in gene expression can be detected using in situ hybridization, in which the expression of the individual cell is analyzed. Our previous attempts to study bFGF 
Tn he intima of normal rat carotid arteries and aortas is usually devoid of smooth muscle cells (SMCs) . A denuding injury of these arteries induces proliferation of SMCs in the tunica media, and the magnitude of the proliferative response depends on the amount of trauma caused by the denuding technique.1 As the proliferative response of SMCs proceeds, migration of SMCs into the intima occurs where the continued replication of these cells leads to the formation of an intimal lesion. 2 We have recently shown that release of endogenous basic fibroblast growth factor (bFGF) from damaged cells in the vessel wall is important for the onset of cell proliferation. 3'4 This was demonstrated by administration of a neutralizing antibody against bFGF, which caused a >90% reduction in medial SMC proliferation measured 2 days after injury.3 When the same antibody was given to animals 6 days after balloon injury, however, it had no effect on replicating intimal SMCs. From these data, it is unclear if bFGF is involved in the continued proliferation of these arterial cells. Northern blot analysis of RNA extracted from the entire vessel wall showed no increase in transcript levels of bFGF. 5 The majority of the cell population in the vessel wall at any given time after injury is not replicating, and any local differences in cellular gene transcription may be overlooked by using Northern analysis of RNA, in which the overall expression of the entire artery is analyzed. Localized differences in gene expression can be detected using in situ hybridization, in which the expression of the individual cell is analyzed. Our previous attempts to study bFGF of endothelial regeneration (up to 6 weeks) were studied in the aorta after total denudation. In these vessels, endothelial regrowth occurred from intercostal arteries. In all animals with denudation of the aorta, simultaneous balloon catheter denudation of the carotid artery was performed. These carotid arteries were used to study SMCs For expression of bFGF, 80 en face preparations were hybridized with the antisense strand, and 60 were probed with the sense strand. For FGFR-1 expression, 33 en face preparations were hybridized with the antisense strand, and 25 specimens were probed with the sense strand. After hybridization (at 55°C overnight), the specimens were washed with 2x standard saline citrate (SSC)/10 mM p-mercaptoethanol/1 mM EDTA (twice for 10 minutes each) (1x SSC contains 150 mM NaCl and 15 mM sodium citrate, pH 7.0), treated with RNase A (20 gg/mL, 30 minutes at 37°C, Sigma Chemical Co, St Louis, Mo), and washed in 2x SSC (as above) followed by a high-stringency wash at 55°C for 2 hours (0.1 x SSC/10 mM 13-mercaptoethanol/1 mM EDTA). Subsequent steps followed the protocol as described.8 The Hautchen procedure for en face preparations9 was carried out after the probe hybridization. Slides were coated with autoradiographic emulsion (Kodak, NTB2), exposed for Replicating endothelial cells were identified by administration of the thymidine analogue BrdU and immunohistochemical staining with an antibody against BrdU. As shown in Fig 1, a, those endothelial cells at the leading edge within 4 days after injury all stained positive with the antibody to BrdU, whereas the endothelium from uninjured arteries showed very low replication.10-'2 At later times after injury, the replication rate of these cells has been found to slow down significantly and to approach that observed in uninjured arteries.10'3 Replication of SMCs in rat carotid arteries has been quantitated extensively in previous studies from this and other laboratories.2 '14 Expression of bFGF and FGFR-1 in Endothelium
We used the en face technique in conjunction with in situ hybridization to investigate the expression of bFGF in the process of endothelial cell replication. Hybridization of unmanipulated endothelium with an antisense probe for rat bFGF revealed no detectable expression of bFGF mRNA (Fig 1, b) . A significant number of endothelial cells at the immediate wound edge expressed mRNA for bFGF within 8 hours after injury, and 4 days later, all endothelial cells at the denuded zone showed expression of bFGF mRNA (Fig 1, c) . At 2 weeks after injury, endothelium at the leading edge still expressed bFGF mRNA, but in endothelial cells further away from the wound edge, expression of bFGF mRNA was not detectable. All en face preparations probed with the labeled bFGF sense strand revealed only background levels of hybridization similar to Fig 1, b .
Immunostaining with an antibody raised against the peptide encoding the first 23 amino acids of rat bFGF showed staining in unmanipulated endothelium (Fig 1,  d ) despite the absence of detectable levels of bFGF mRNA. The staining appeared to be restricted to the nucleus. Immunoreactivity for bFGF was also found in replicating endothelium, which in addition to nuclear staining also revealed cytoplasmic staining (Fig 1, e) . All tissue specimens incubated with nonimmune IgG showed no staining.
Expression of one of the fibroblast growth factor receptors was studied in these arteries at the same time points after denudation as bFGF. FGFR-1 mRNA15""6 was not detected by in situ hybridization in endothelium of unmanipulated arteries (Fig 1, f) ; however, FGFR-1 mRNA was found in injured arteries when the endothelium was replicating rapidly (Fig 1, g ). This expression was seen at the leading edge of the endothelial monolayer of partially denuded aortas within 8 hours. At sites away from the wound edge, only occasional endothelial cells expressed FGFR-1 mRNA. At later times after injury (2 to 6 weeks), the regenerated endothelium revealed no detectable levels of FGFR-1 mRNA expression similar to uninjured endothelium (Fig 1, f) . No hybridization occurred when en face preparations of endothelium were incubated with the labeled sense strand for FGFR-1 (similar to Fig 1, f) .
Expression of bFGF in SMCs
We were unable to detect the transcript for bFGF in SMCs using cross sections of arterial tissue. In situ hybridization on en face preparations of injured carotid arteries revealed that replicating SMCs appearing on the luminal surface at 4 to 8 days after injury (Fig 2, a) were positive for the bFGF transcript (Fig 2, b) . We were unable to examine SMCs before this time since SMCs start to migrate into the intima at approximately 4 days after injury. Six weeks after injury, when SMCs were no longer proliferating,214 bFGF mRNA in these intimal SMCs was not detectable (Fig 2, c) . Immunostaining showed bFGF protein in both the nucleus and the cytoplasm (Fig 2, d ) in replicating SMCs, but immunoreactivity for bFGF in quiescent SMCs appeared to be only in the nucleus (Fig 2, e) . No staining was seen with nonimmune IgG.
Using the same en face procedure to look for expression of FGFR-1, we observed that, at both early (Fig 2,  f) and later (Fig 2, g) Using in situ hybridization on en face preparations of rat arteries, we made the following observations. In normal uninjured arteries, mRNA for bFGF and FGFR-1 was not detected in endothelial cells, although by immunocytochemistry nuclear staining for bFGF was apparent. After injury and corresponding to a time of increased cell replication, many endothelial cells, especially those close to the wound edge, expressed bFGF mRNA. Endothelial cells also expressed FGFR-1 mRNA at these times, suggesting that bFGF may be acting in an autocrine manner. This hypothesis is supported by the observation that, when the endothelium stopped replicating, bFGF mRNA levels were undetectable. The SMCs in arteries 4 to 8 days after injury also expressed bFGF mRNA, although, unlike endothelium, no modulation of FGFR-1 transcript levels was observed. At late times after denudation (6 weeks), mRNA for bFGF was not detectable in intimal SMCs.
These data suggest that endogenously synthesized bFGF may play a role in the replication of both endothelial and smooth muscle cells after injury. It must be noted, however, that bFGF is not a secreted peptide17 and therefore any hypothesis that implicates bFGF synthesis as being important for cell replication must also explain how it can interact with the high-affinity receptors on the cell membrane. One possibility is that bFGF is not required to exit the cell in order to initiate a mitogenic effect, and such an intracrine pathway has been suggested by others.18 With reference to this issue, we have not been able to influence the growth of endothelial cells19 or intimal smooth muscle cells5 in vivo by the use of neutralizing antibodies to bFGF. The results of those experiments are consistent with the idea that bFGF may be acting intracellularly. In cultured cells, however, Mignatti et a120 have provided evidence for a mechanism of bFGF release from cells. The authors showed that bFGF can be released from cultured 3T3 cells transfected with bFGF cDNA via a mechanism of exocytosis that is independent of the endoplasmatic reticulum-Golgi pathway. Alternatively, nonlethal trauma to cells with transient defects in their cell membranes has been shown to allow release of bFGF.2122 Of particular interest with regard to this mechanism is a report by Yu and McNeil,23 who have shown that blood flow can cause membrane disruptions in endothelial cells. It is questionable whether bFGF would be released via this mechanism from quiescent cells in which bFGF appears to be localized in the nucleus. However, it is possible that bFGF may be released from replicating cells through plasma membrane disruptions, since in these cells bFGF appears to be present also in the cytoplasm. Thus, it is possible that local release of bFGF from endothelial cells and possibly from SMCs is responsible for the observed cell growth. At present, however, there are no data to confirm if such a mechanism may be important for cell replication.
In summary, the present study shows that it is possible to detect mRNA for both bFGF and FGFR-1 using an in situ hybridization procedure in which the luminal cells are examined using en face techniques. Since these transcripts cannot be detected on cross sections of these same arteries, we suggest that this technique has enhanced sensitivity to detect low levels of mRNA. We observed that both endothelial and smooth muscle cells difference in cell replication. 2, 5, 14 Lindner and Reidy bFGF and FGFR-1 Expression in Injured Artenres 595 expressed bFGF and FGFR-1 mRNA at early times after injury and that there was a marked downregulation of bFGF mRNA in these cells at later times, when cell replication is known to have ceased. This association of cell replication and expression of bFGF might suggest an endogenous pathway for the stimulation of these cells, but it is not clear how this process may occur nor whether it is necessary for the replication of either endothelial or smooth muscle cells.
